Alkermes to Participate in Two Upcoming Investor Conferences

Source: Eagle-Tribune

DUBLIN, May 29, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in fireside chat presentations at two upcoming investor conferences.

Jefferies Healthcare Conference

Date/Time: Thursday, June 6, 2024 at 1:30 p.m. EDT (6:30 p.m. BST)

Goldman Sachs 45th Annual Global Healthcare Conference

Date/Time: Tuesday, June 11, 2024 at 10:40 a.m. EDT (3:40 p.m. BST)

The live webcasts may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders, including narcolepsy. Headquartered in Ireland, Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Alkermes Contact:

Jamie Constantine

Investor Relations

+1 781 873 2402

View original content to download multimedia: https://www.prnewswire.com/news-releases/alkermes-to-participate-in-two-upcoming-investor-conferences-302158279.html

SOURCE Alkermes plc